Description

L-Lysine Mono[[6R-[6Alpha,7Beta(R*)]]-7-[(Aminophenylacetyl)Amino]-3-Methyl-8-Oxo-5-Thia-1-Azabicyclo[4.2.0]Oct-2-Ene-2-Carboxylate] is a specialized derivative of the essential amino acid L-Lysine, chemically modified with a cephalosporin-based moiety. This compound is of significant interest for its potential role in the research and development of novel pharmaceutical agents, particularly in the field of antimicrobial and prodrug strategies. It serves as a critical advanced pharmaceutical intermediate and a valuable tool for researchers in medicinal chemistry and pharmacology.

Application

This specialized lysine derivative is utilized in advanced research and development settings. Its primary applications include:

• Pharmaceutical Intermediate: Serving as a key building block in the synthesis of novel cephalosporin-antibiotic conjugates and targeted drug delivery systems.
• Medicinal Chemistry Research: Acting as a precursor for the development of new chemical entities with potential antimicrobial, anti-inflammatory, or other therapeutic activities.
• Prodrug Development: Used in studies aimed at creating prodrugs designed to improve the bioavailability or targeting of active pharmaceutical ingredients.
• Biochemical Research: Employed as a substrate or inhibitor in enzymatic studies to explore specific biochemical pathways.
• Peptide Modification: Used to introduce specific functional groups or antibiotic motifs into synthetic peptides for structure-activity relationship (SAR) studies.

Basic Information

Product Name	L-Lysine Mono[[6R-[6Alpha,7Beta(R*)]]-7-[(Aminophenylacetyl)Amino]-3-Methyl-8-Oxo-5-Thia-1-Azabicyclo[4.2.0]Oct-2-Ene-2-Carboxylate]
CAS No.	53950-14-4
Molecular Formula	C₂₃H₂₉N₅O₆S
Molecular Weight	503.57 g/mol
Synonyms	L-Lysine, mono[6R-[6α,7β(R*)]]-7-[(aminophenylacetyl)amino]-3-methyl-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate; Lysine Cephalosporin Derivative; (6R,7R)-7-[(R)-2-Amino-2-phenylacetamido]-3-methyl-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid compound with L-lysine (1:1); Cephalosporin Lysine Salt; Antibiotic-Lysine Conjugate.
EINECS	Contact for details

Quality Control

Our production of this high-purity research chemical adheres to stringent quality protocols. Each batch undergoes comprehensive analytical testing, including HPLC for purity assessment and spectroscopic methods for structural confirmation. Certificates of Analysis (COA) detailing identity, purity, and impurity profiles are provided to ensure traceability and support your research integrity. We can supply material compliant with relevant ICH guidelines for impurity profiling.

Storage

Preserve in a tightly closed container, protected from light. Store in a cool, dry place at a controlled room temperature (15-25°C). This compound is hygroscopic (moisture-sensitive) and should be handled in a dry environment to prevent degradation. For long-term storage, consider desiccated conditions.

Specification

Item	Specification
Appearance	White to off-white powder
Identification (IR)	Conforms to structure
Identification (HPLC)	Retention time matches reference standard
Purity (HPLC)	≥ 95.0%
Water Content (KF)	≤ 5.0%
Heavy Metals	≤ 20 ppm
Residual Solvents (GC)	Complies with ICH Q3C

Note: Specifications can be tailored. Please contact us for the detailed technical data sheet of a specific grade.